- Home
- J&J Innovative Medicine
J&J Innovative Medicine
5 things we now know about myasthenia gravis
For Myasthenia Gravis Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.
By the numbers: Understanding the toll of inflammatory bowel disease
For Colitis and Crohn’s Disease Awareness Week, learn about the challenges of this painful condition—and why Johnson & Johnson continues to seek new treatment options.
“My battle with IBD has fueled my passion for helping patients like me”
Sid Jain, a leader on the pharmaceutical R&D data science team at Johnson & Johnson, knows that new and better treatment options change lives. And being a Crohn’s disease patient himself has supercharged his mission to help revolutionize the research process.
What you need to know about Johnson & Johnson’s 2023 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Johnson & Johnson named to Fortune‘s 2023 America’s Most Innovative Companies list
The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson’s mission to improve health for people across the globe for over a century.
What is a rare disease?
It’s estimated that over 300 million people around the globe are living with a rare disease. For Rare Disease Day, here’s what to know.
Microbiome researcher Jeffrey Gordon receives the 2022 Dr. Paul Janssen Award for biomedical research
Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.
Johnson & Johnson named a 2023 Fortune World’s Most Admired Company and ranked #1 on the Pharmaceutical Industry list.
A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.
What you need to know about Johnson & Johnson’s 2022 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
What happens when antibiotics stop working?
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.